Helius Medical Stock (NASDAQ:HSDT)
Previous Close
$0.56
52W Range
$0.37 - $9.50
50D Avg
$0.61
200D Avg
$2.40
Market Cap
$1.92M
Avg Vol (3M)
$444.66K
Beta
1.61
Div Yield
-
HSDT Company Profile
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
HSDT Performance
Peer Comparison
| Ticker | Company |
|---|---|
| RPID | Rapid Micro Biosystems, Inc. |
| SGHT | Sight Sciences, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| NUWE | Nuwellis, Inc. |
| AZYO | Elutia Inc. |
| RSLS | ReShape Lifesciences Inc. |
| BBLG | Bone Biologics Corporation |
| BJDX | Bluejay Diagnostics, Inc. |
| HSCS | Heart Test Laboratories, Inc. |
| SINT | Sintx Technologies, Inc. |
| VVOS | Vivos Therapeutics, Inc. |